<DOC>
	<DOCNO>NCT01836497</DOCNO>
	<brief_summary>The study design confirm safety efficacy SD01 ICD ( implantable cardioverter-defibrillator ) lead .</brief_summary>
	<brief_title>SD01 Master Study ( Safety Efficacy Study )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>Standard indication ICD/CRTD therapy Signed informed consent form Patient willing able participate whole study duration Patient willing able activate use CardioMessenger Legal capacity ability consent . Standard contraindication ICD/CRTD therapy Age &lt; 18 year . Pregnant breastfeeding Cardiac surgery plan within next six month Any condition opinion investigator would preclude compliance study protocol whole followup period Enrollment another cardiac clinical investigation active treatment arm Mechanical tricuspid valve prosthesis severe tricuspid valve disease Dexamethasone acetate intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>